1. Home
  2. SITM vs GH Comparison

SITM vs GH Comparison

Compare SITM & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SITM
  • GH
  • Stock Information
  • Founded
  • SITM 2003
  • GH 2011
  • Country
  • SITM United States
  • GH United States
  • Employees
  • SITM N/A
  • GH N/A
  • Industry
  • SITM Semiconductors
  • GH Medical Specialities
  • Sector
  • SITM Technology
  • GH Health Care
  • Exchange
  • SITM Nasdaq
  • GH Nasdaq
  • Market Cap
  • SITM 5.3B
  • GH 4.9B
  • IPO Year
  • SITM 2019
  • GH 2018
  • Fundamental
  • Price
  • SITM $197.08
  • GH $45.54
  • Analyst Decision
  • SITM Strong Buy
  • GH Strong Buy
  • Analyst Count
  • SITM 5
  • GH 19
  • Target Price
  • SITM $228.00
  • GH $55.11
  • AVG Volume (30 Days)
  • SITM 293.3K
  • GH 1.8M
  • Earning Date
  • SITM 08-06-2025
  • GH 07-30-2025
  • Dividend Yield
  • SITM N/A
  • GH N/A
  • EPS Growth
  • SITM N/A
  • GH N/A
  • EPS
  • SITM N/A
  • GH N/A
  • Revenue
  • SITM $229,989,000.00
  • GH $773,996,000.00
  • Revenue This Year
  • SITM $38.21
  • GH $23.37
  • Revenue Next Year
  • SITM $23.79
  • GH $21.31
  • P/E Ratio
  • SITM N/A
  • GH N/A
  • Revenue Growth
  • SITM 65.85
  • GH 28.20
  • 52 Week Low
  • SITM $105.40
  • GH $20.14
  • 52 Week High
  • SITM $268.18
  • GH $53.42
  • Technical
  • Relative Strength Index (RSI)
  • SITM 40.96
  • GH 35.84
  • Support Level
  • SITM $189.00
  • GH $43.25
  • Resistance Level
  • SITM $200.00
  • GH $46.62
  • Average True Range (ATR)
  • SITM 8.51
  • GH 1.54
  • MACD
  • SITM -2.06
  • GH -0.61
  • Stochastic Oscillator
  • SITM 13.40
  • GH 10.91

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: